SEC61G identified as a pan-cancer biomarker and potential therapeutic target
SEC61G exhibits independent oncogenic functions across multiple cancers and serves as a prognostic biomarker.
Therapeutic Area
Therapeutic area intelligence for Biomarker Discovery with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No related entities indexed yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.